In This Store
Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:EPIAO
CAS No.:-
Standard:In-house Standards
Price(USD):0.00
Company:3SBIO INC.
Grade: Pharmaceutical Grade
Factory Location: Shenyang Liaoning China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Erythropoietin is a glycoprotein that excreted in the kidney and stimulates the proliferation and differentiation of committed erythroid progenitors in the bone marrow. It can increase the production of Red Blood Cells.
Indications: Anemia associated with renal failure: including patients on hemodialysis (HD) and non-dialysis (ND), peri-operative red blood cell mobilization, and anemia associated with chemotherapy in cancer patients with non-myeloid malignancies. EPIAO is firstly approved for the treatment of peri-operative red blood cell mobilization and anemia associated with chemotherapy in cancer patients in China.
10,000IU/vial is the unique specification developed by 3SBio, which could be used conveniently in all above-mentioned indications. In 2011, the SFDA approved a 36,000 IU formulation for chemotherapy indications
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us: